GEV vs. LLY: A Head-to-Head Stock Comparison

Updated on August 29, 2025

Here’s a clear look at GEV and LLY, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Symbol	GEV	LLY
Company Name	GE Vernova Inc.	Eli Lilly and Company
Country	United States	United States
GICS Sector	Industrials	Health Care
GICS Industry	Electrical Equipment	Pharmaceuticals
Market Capitalization	169.43 billion USD	658.15 billion USD
Exchange	NYSE	NYSE
Listing Date	March 27, 2024	June 1, 1972
Security Type	Common Stock	Common Stock

Historical Performance

This chart compares the performance of GEV and LLY by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

GEV vs. LLY: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	GEV	LLY
5-Day Price Return	2.70%	3.43%
13-Week Price Return	32.00%	1.23%
26-Week Price Return	89.82%	-15.97%
52-Week Price Return	241.73%	-22.76%
Month-to-Date Return	-5.74%	-0.80%
Year-to-Date Return	89.22%	-4.90%
10-Day Avg. Volume	2.53M	5.35M
3-Month Avg. Volume	2.99M	4.49M
3-Month Volatility	41.46%	41.89%
Beta	1.61	0.45

Profitability

Return on Equity (TTM)

GEV

12.65%

Electrical Equipment Industry

Max: 37.56%
Q3: 20.60%
Median: 14.38%
Q1: 4.35%
Min: 0.90%

GEV’s Return on Equity of 12.65% is on par with the norm for the Electrical Equipment industry, indicating its profitability relative to shareholder equity is typical for the sector.

LLY

88.36%

Pharmaceuticals Industry

Max: 38.59%
Q3: 19.84%
Median: 11.90%
Q1: 5.63%
Min: -9.96%

LLY’s Return on Equity of 88.36% is exceptionally high, placing it well beyond the typical range for the Pharmaceuticals industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

GEV vs. LLY: A comparison of their Return on Equity (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Net Profit Margin (TTM)

GEV

3.15%

Electrical Equipment Industry

Max: 20.43%
Q3: 10.97%
Median: 6.07%
Q1: 3.16%
Min: 0.29%

Falling into the lower quartile for the Electrical Equipment industry, GEV’s Net Profit Margin of 3.15% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

LLY

25.91%

Pharmaceuticals Industry

Max: 34.51%
Q3: 17.73%
Median: 12.12%
Q1: 5.99%
Min: -7.73%

A Net Profit Margin of 25.91% places LLY in the upper quartile for the Pharmaceuticals industry, signifying strong profitability and more effective cost management than most of its peers.

GEV vs. LLY: A comparison of their Net Profit Margin (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Operating Profit Margin (TTM)

GEV

2.65%

Electrical Equipment Industry

Max: 26.20%
Q3: 14.31%
Median: 7.54%
Q1: 3.77%
Min: -5.64%

GEV’s Operating Profit Margin of 2.65% is in the lower quartile for the Electrical Equipment industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

LLY

32.37%

Pharmaceuticals Industry

Max: 41.53%
Q3: 23.00%
Median: 16.24%
Q1: 9.24%
Min: -6.94%

An Operating Profit Margin of 32.37% places LLY in the upper quartile for the Pharmaceuticals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

GEV vs. LLY: A comparison of their Operating Profit Margin (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Profitability at a Glance

Symbol	GEV	LLY
Return on Equity (TTM)	12.65%	88.36%
Return on Assets (TTM)	2.23%	16.02%
Net Profit Margin (TTM)	3.15%	25.91%
Operating Profit Margin (TTM)	2.65%	32.37%
Gross Profit Margin (TTM)	18.47%	82.64%

Financial Strength

Current Ratio (MRQ)

GEV

1.03

Electrical Equipment Industry

Max: 3.02
Q3: 1.99
Median: 1.41
Q1: 1.07
Min: 0.80

GEV’s Current Ratio of 1.03 falls into the lower quartile for the Electrical Equipment industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

LLY

1.28

Pharmaceuticals Industry

Max: 4.49
Q3: 2.77
Median: 1.74
Q1: 1.26
Min: 0.11

LLY’s Current Ratio of 1.28 aligns with the median group of the Pharmaceuticals industry, indicating that its short-term liquidity is in line with its sector peers.

GEV vs. LLY: A comparison of their Current Ratio (MRQ) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Debt-to-Equity Ratio (MRQ)

GEV

0.00

Electrical Equipment Industry

Max: 1.44
Q3: 0.99
Median: 0.56
Q1: 0.24
Min: 0.00

Falling into the lower quartile for the Electrical Equipment industry, GEV’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

LLY

2.18

Pharmaceuticals Industry

Max: 2.44
Q3: 1.07
Median: 0.42
Q1: 0.11
Min: 0.00

LLY’s leverage is in the upper quartile of the Pharmaceuticals industry, with a Debt-to-Equity Ratio of 2.18. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

GEV vs. LLY: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Interest Coverage Ratio (TTM)

GEV

-0.05

Electrical Equipment Industry

Max: 36.12
Q3: 19.29
Median: 9.38
Q1: 1.16
Min: -10.92

GEV has a negative Interest Coverage Ratio of -0.05. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

LLY

20.36

Pharmaceuticals Industry

Max: 103.95
Q3: 44.18
Median: 9.83
Q1: 2.82
Min: -42.71

LLY’s Interest Coverage Ratio of 20.36 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.

GEV vs. LLY: A comparison of their Interest Coverage Ratio (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Financial Strength at a Glance

Symbol	GEV	LLY
Current Ratio (MRQ)	1.03	1.28
Quick Ratio (MRQ)	0.74	0.53
Debt-to-Equity Ratio (MRQ)	0.00	2.18
Interest Coverage Ratio (TTM)	-0.05	20.36

Growth

Revenue Growth

GEV vs. LLY: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

GEV vs. LLY: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

GEV

0.00%

Electrical Equipment Industry

Max: 2.20%
Q3: 1.53%
Median: 1.01%
Q1: 0.00%
Min: 0.00%

GEV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

LLY

0.77%

Pharmaceuticals Industry

Max: 6.98%
Q3: 3.32%
Median: 2.13%
Q1: 0.14%
Min: 0.00%

LLY’s Dividend Yield of 0.77% is consistent with its peers in the Pharmaceuticals industry, providing a dividend return that is standard for its sector.

GEV vs. LLY: A comparison of their Dividend Yield (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Dividend Payout Ratio (TTM)

GEV

0.00%

Electrical Equipment Industry

Max: 119.44%
Q3: 51.87%
Median: 27.71%
Q1: 0.00%
Min: 0.00%

GEV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

LLY

36.46%

Pharmaceuticals Industry

Max: 165.20%
Q3: 90.59%
Median: 49.13%
Q1: 28.91%
Min: 0.00%

LLY’s Dividend Payout Ratio of 36.46% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

GEV vs. LLY: A comparison of their Dividend Payout Ratio (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Dividend at a Glance

Symbol	GEV	LLY
Dividend Yield (TTM)	0.00%	0.77%
Dividend Payout Ratio (TTM)	0.00%	36.46%

Valuation

Price-to-Earnings Ratio (TTM)

GEV

142.50

Electrical Equipment Industry

Max: 81.85
Q3: 44.17
Median: 27.61
Q1: 18.62
Min: 7.73

At 142.50, GEV’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Electrical Equipment industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

LLY

47.48

Pharmaceuticals Industry

Max: 42.51
Q3: 26.88
Median: 19.11
Q1: 15.12
Min: 0.00

At 47.48, LLY’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Pharmaceuticals industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

GEV vs. LLY: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Price-to-Sales Ratio (TTM)

GEV

4.50

Electrical Equipment Industry

Max: 8.18
Q3: 4.02
Median: 1.84
Q1: 0.97
Min: 0.44

GEV’s P/S Ratio of 4.50 is in the upper echelon for the Electrical Equipment industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

LLY

12.30

Pharmaceuticals Industry

Max: 7.55
Q3: 4.54
Median: 2.11
Q1: 1.52
Min: 0.00

With a P/S Ratio of 12.30, LLY trades at a valuation that eclipses even the highest in the Pharmaceuticals industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

GEV vs. LLY: A comparison of their Price-to-Sales Ratio (TTM) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Price-to-Book Ratio (MRQ)

GEV

16.27

Electrical Equipment Industry

Max: 8.50
Q3: 4.53
Median: 3.39
Q1: 1.70
Min: 0.51

At 16.27, GEV’s P/B Ratio is at an extreme premium to the Electrical Equipment industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

LLY

40.43

Pharmaceuticals Industry

Max: 9.78
Q3: 4.96
Median: 2.23
Q1: 1.46
Min: 0.60

At 40.43, LLY’s P/B Ratio is at an extreme premium to the Pharmaceuticals industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

GEV vs. LLY: A comparison of their Price-to-Book Ratio (MRQ) against their respective Electrical Equipment and Pharmaceuticals industry benchmarks.

Valuation at a Glance

Symbol	GEV	LLY
Price-to-Earnings Ratio (TTM)	142.50	47.48
Price-to-Sales Ratio (TTM)	4.50	12.30
Price-to-Book Ratio (MRQ)	16.27	40.43
Price-to-Free Cash Flow Ratio (TTM)	60.78	326.03